Delivery Order SPE2DB20D3103-SPE2DB25FQ0U4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $4,698.53. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $2,511.68. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. As a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180 count) with a ceiling value of $6,794.09. This competitive delivery order, issued under firm fixed price terms, represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the DLA. The place of performance is located at the vendor's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $19,423.78. This firm fixed-price delivery order represents a non-set-aside, competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The ultimate completion date for this delivery order is August 5,...
- The Defense Logistics Agency awarded a delivery order valued at $3,537.29 to AmerisourceBergen Drug Corp for Janumet XR 50-1,000 mg tablets (60-count) on August 21, 2025, with completion targeted for August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $1,991.88. This is a firm fixed-price delivery order issued without a set-aside designation, indicating competitive award eligibility. The product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.12 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-500 mg tablets (180-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger federal contracting relationship with DLA. The place of performance is located at the contractor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-500 mg tablets (180-count) under a firm fixed-price contract valued at $2,653.97. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this medical supply requirement. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,224.07. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0U4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180 count) with a ceiling value of $10,520.81. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The SPE2DX IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems globally. Through this prime vendor relationship, AmerisourceBergen provides specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, positioning AmerisourceBergen as one of the key pharmaceutical support providers for federal military healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 8/28/25 |